Quantcast
Last updated on April 18, 2014 at 0:13 EDT

Latest Cambrex Corporation Stories

2014-04-16 12:31:12

DUBLIN, Apr. 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kmjbrh/flow_chemistry ) has announced the addition of the "Flow Chemistry Market by Reactor Type (CSTR, Plug Flow Reactor, Microreactor, Microwave System), Application & Geography - Trends & Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The continuous flow reactor market is witnessing a significant growth globally, due to...

2014-04-11 12:25:06

DUBLIN, April 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zxblrf/global_chiral) has announced the addition of the "Global Chiral Technology Market Report" [http://www.researchandmarkets.com/research/zxblrf/global_chiral ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Chiral Technology market to grow at a CAGR of 14.53 percent...

2014-04-02 12:32:17

EAST RUTHERFORD, N.J., April 2, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the 13(th) Annual Needham Healthcare Conference on April 9, 2014 at 4:20 p.m. EDT in New York City. The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be...

2014-02-11 08:31:28

- Strong increase in fourth quarter and full year Sales and EBITDA - EAST RUTHERFORD, N.J., Feb. 11, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports results for the fourth quarter and full year ended December 31, 2013. Highlights -- Fourth quarter sales increased 46.3% to $103.0 million from $70.4 million in the same period last year. Full year sales increased 14.1% and 12.8% excluding the impact of foreign currency. -- Fourth quarter EBITDA increased...

2014-02-07 16:24:26

EAST RUTHERFORD, N.J., Feb. 7, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that fourth quarter 2013 financial results will be released on Tuesday, February 11, 2014 before the market opens. The Company will host a conference call to discuss the financial results. Fourth Quarter 2013 Earnings Conference Call -------------------------------------------- When: Tuesday,...

2014-02-07 08:22:19

DUBLIN, Feb. 7, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/4m8hf7/flow_chemistry) has announced the addition of the "Flow Chemistry Market by Reactor Type (CSTR, Plug Flow Reactor, Microreactor, Microwave System), Application & Geography - Trends & Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The continuous flow reactor market is witnessing a significant growth globally, due to various...

2014-01-20 12:24:57

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analyzing the Global Market for Active Pharmaceutical Ingredients The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the...

2013-12-16 16:25:28

EAST RUTHERFORD, N.J., Dec. 16, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") announced that the US Food and Drug Administration (FDA) completed an inspection of Cambrex's active pharmaceutical ingredient (API) manufacturing facility in Charles City, Iowa. The inspection found the site to be compliant with the principles and guidelines of Good Manufacturing Practice (GMP) and no Form 483 observations were issued. The US FDA authorities inspected the facility from...

2013-12-04 16:25:09

EAST RUTHERFORD, N.J., Dec. 4, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will make a presentation on the Company at the Oppenheimer 24(th) Annual Healthcare Conference on December 10, 2013 at 4:30 p.m. EST, in New York City. The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts &...

2013-12-02 08:24:13

DUBLIN, December 2, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/64fm65/global_chiral) has announced the addition of the "Global Chiral Technology Market 2012-2016" [http://www.researchandmarkets.com/research/64fm65/global_chiral ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) One of the key factors contributing to this market growth is favorable government regulations for chiral...